AC Immune S.A. (ACIU) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
AC Immune S.A. (ACIU) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $289.0M, listed on NASDAQ, employing roughly 133 people, carrying a beta of 1.63 to the broader market. AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Led by Andrea Pfeifer, public since 2016-09-23.
Snapshot as of May 15, 2026.
- Spot Price
- $2.81
- Total OI
- 10.1K